The Independent on MSN11d
Cancer vaccine being created by UK scientists could stop disease up to 20 years earlyPharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the ...
Hosted on MSN1mon
Don't ignore the burning rash: Shingles risk for adults over 50KUALA LUMPUR - Shingles, a viral disease caused by the varicella zoster virus (VZV), the same virus responsible for chickenpox, poses a significant risk to older adults due to the natural decline ...
Drugmaker GSK has agreed to pay up to 1.15 billion US dollars (£950 million) for a US-based biopharmaceutical company which is developing rare cancer therapies. GSK said the acquisition of IDRx w ...
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio. The purchase ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback